Does PAZOPANIB Cause Hepatic neoplasm? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Hepatic neoplasm have been filed in association with PAZOPANIB (Pazopanib). This represents 0.1% of all adverse event reports for PAZOPANIB.
16
Reports of Hepatic neoplasm with PAZOPANIB
0.1%
of all PAZOPANIB reports
6
Deaths
5
Hospitalizations
How Dangerous Is Hepatic neoplasm From PAZOPANIB?
Of the 16 reports, 6 (37.5%) resulted in death, 5 (31.3%) required hospitalization.
Is Hepatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Malignant neoplasm progression (1,471)
Drug ineffective (1,135)
Decreased appetite (1,116)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
What Other Drugs Cause Hepatic neoplasm?
OCTREOTIDE (300)
ADALIMUMAB (98)
LANREOTIDE (85)
EVEROLIMUS (84)
AMLODIPINE (74)
ROSUVASTATIN (55)
IMATINIB (51)
BEVACIZUMAB (49)
RIBAVIRIN (49)
METFORMIN (47)
Which PAZOPANIB Alternatives Have Lower Hepatic neoplasm Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS